pk 11195 has been researched along with Nervous System Diseases in 2 studies
PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine
Nervous System Diseases: Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Venneti, S | 1 |
| Wang, G | 1 |
| Nguyen, J | 1 |
| Wiley, CA | 1 |
| MacGregor, DG | 1 |
| Stone, TW | 1 |
2 other studies available for pk 11195 and Nervous System Diseases
| Article | Year |
|---|---|
The positron emission tomography ligand DAA1106 binds with high affinity to activated microglia in human neurological disorders.
Topics: Acetamides; Aged; Aged, 80 and over; Autoradiography; Brain; Female; Humans; Inflammation; Isoquinol | 2008 |
Inhibition by the adenosine analogue, (R-)-N6-phenylisopropyladenosine, of kainic acid neurotoxicity in rat hippocampus after systemic administration.
Topics: Animals; Behavior, Animal; Body Temperature; Hippocampus; Isoquinolines; Kainic Acid; Kinetics; Male | 1993 |